Eclavia, Ayara Amber .
HRN: 25-29-21 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/02/2024
AMPICILLIN 1GM (VIAL)
10/02/2024
10/08/2024
IVT
300mg
Q8
Impetigo
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes